These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38192158)

  • 21. INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity.
    Rooper LM; Sharma R; Li QK; Illei PB; Westra WH
    Am J Surg Pathol; 2017 Nov; 41(11):1561-1569. PubMed ID: 28719469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulinoma-associated Protein 1 (INSM1) in Thoracic Tumors is Less Sensitive but More Specific Compared With Synaptophysin, Chromogranin A, and CD56.
    Kriegsmann K; Zgorzelski C; Kazdal D; Cremer M; Muley T; Winter H; Longuespée R; Kriegsmann J; Warth A; Kriegsmann M
    Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):237-242. PubMed ID: 30358615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience.
    Rodriguez EF; Fite JJ; Chowsilpa S; Maleki Z
    Hum Pathol; 2019 Mar; 85():128-135. PubMed ID: 30502379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors.
    Möller K; Uhlig R; Gorbokon N; Dum D; Menz A; Büscheck F; Luebke AM; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Lebok P; Weidemann S; Lennartz M; Jacobsen F; Clauditz TS; Steurer S; Burandt E; Krech R; Krech T; Marx AH; Sauter G; Simon R; Bernreuther C; Minner S
    Mol Cell Endocrinol; 2024 Feb; 581():112106. PubMed ID: 37951531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. INSM1 expression in a subset of thoracic malignancies and small round cell tumors: rare potential pitfalls for small cell carcinoma.
    Tsai HK; Hornick JL; Vivero M
    Mod Pathol; 2020 Aug; 33(8):1571-1580. PubMed ID: 32203089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulinoma-associated Protein 1 Expression and Its Diagnostic Significance in Female Genital Tract Neuroendocrine Carcinomas.
    Ting CH; Wang TY; Wu PS
    Int J Gynecol Pathol; 2021 Sep; 40(5):452-459. PubMed ID: 33323849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer.
    Fujino K; Motooka Y; Hassan WA; Ali Abdalla MO; Sato Y; Kudoh S; Hasegawa K; Niimori-Kita K; Kobayashi H; Kubota I; Wakimoto J; Suzuki M; Ito T
    Am J Pathol; 2015 Dec; 185(12):3164-77. PubMed ID: 26482608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SOX11 is a sensitive and specific marker for pulmonary high-grade neuroendocrine tumors.
    Yu L; Dong Y; Xue J; Xu S; Wang G; Kuang D; Duan Y
    Diagn Pathol; 2022 Jan; 17(1):2. PubMed ID: 34996493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroendocrine differentiation in a large series of genetically-confirmed Ewing's sarcoma family tumor: Does it provide any diagnostic or prognostic information?
    Machado I; Navarro S; López-Guerrero JA; Verdini L; Picci P; Giner F; Llombart-Bosch A
    Pathol Res Pract; 2021 Mar; 219():153362. PubMed ID: 33610950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic Utility of INSM1 in Medullary Thyroid Carcinoma.
    Seok JY; Kang M; De Peralta-Venturina M; Fan X
    Int J Surg Pathol; 2021 Sep; 29(6):615-626. PubMed ID: 33650906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. INSM1 immunostaining in solid papillary carcinoma of the breast.
    Kudo N; Takano J; Kudoh S; Arima N; Ito T
    Pathol Int; 2021 Jan; 71(1):51-59. PubMed ID: 33156579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of p63, p40 and CK5/6 in small cell lung cancer].
    Zhang L; Hou L; Xie H; Dong Z; Wu W; Kong J; Chen G; Wu C
    Zhonghua Bing Li Xue Za Zhi; 2015 Sep; 44(9):644-7. PubMed ID: 26705280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P16 is a useful supplemental diagnostic marker of pulmonary small cell carcinoma in small biopsies and cytology specimens.
    Švajdler M; Mezencev R; Ondič O; Šašková B; Mukenšnábl P; Michal M
    Ann Diagn Pathol; 2018 Apr; 33():23-29. PubMed ID: 29566943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INSM1 expression in neuroendocrine tumors in a tertiary care hospital.
    Chandrasekaran K; Sundaram S; Balasubramanian S
    J Cancer Res Ther; 2024 Apr; 20(3):811-816. PubMed ID: 39023587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous multi-antibody staining in non-small cell lung cancer strengthens diagnostic accuracy especially in small tissue samples.
    Kayser G; Csanadi A; Otto C; Plönes T; Bittermann N; Rawluk J; Passlick B; Werner M
    PLoS One; 2013; 8(2):e56333. PubMed ID: 23418554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine tumors.
    Zheng G; Ettinger DS; Maleki Z
    Acta Cytol; 2013; 57(3):281-90. PubMed ID: 23635388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploration of INSM1 and hASH1 as additional markers in lung cytology samples of high-grade neuroendocrine carcinoma with indeterminate neuroendocrine differentiation.
    Rothrock AT; Stewart J; Li F; Racila E; Amin K
    Diagn Cytopathol; 2022 May; 50(5):230-234. PubMed ID: 35147301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The panel of syntaxin 1 and insulinoma-associated protein 1 outperforms classic neuroendocrine markers in pulmonary neuroendocrine neoplasms.
    Zombori T; Turkevi-Nagy S; Sejben A; Juhász-Nagy G; Cserni G; Furák J; Tiszlavicz L; Krenács L; Kővári B
    APMIS; 2021 Apr; 129(4):186-194. PubMed ID: 33417719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. INSM1 expression in primary and metastatic neuroendocrine neoplasms at distinct locations.
    Wang XQ; Fu J; Zhang YT; Xu Y
    Pathol Res Pract; 2024 Jan; 253():155067. PubMed ID: 38171081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Syntaxin-1 and Insulinoma-Associated Protein 1 Expression in Breast Neoplasms with Neuroendocrine Features.
    Turkevi-Nagy S; Báthori Á; Böcz J; Krenács L; Cserni G; Kővári B
    Pathol Oncol Res; 2021; 27():1610039. PubMed ID: 34764822
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.